1. Kleihues P, Schauble B, zur Hausen A, et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol. 1997;150:1-13.

2. Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol. 2000;31:532-538.

3. Bennicelli JL, Barr FG. Chromosomal translocations and sarcomas. Curr Opin Oncol. 2002;14:412-419.

4. Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569-576.

5. Simon MP, Pedeutour F, Sirbent N, et al. Deregulation of the platelet-derived growth factor beta-chain via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant cell fibrob-lastoma. Nat Genet. 1997;15:95-98.

6. Greco A, Roccato E, Miranda C, et al. Growth-inhibitory effect of STI571 on cells transformed by the COL1A1-PDGFB rearrangement. Int J Cancer. 2001;92:354-360.

7. Ladanyi M,Lui MY,Antonescu CR,et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fused the TFE3 transcription factor gene to ASPL,a novel gene at 17q25. Oncogene. 2001;20:48-57.

8. Koontz JI, Soreng AL, Nucci M, et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A. 2001;98:6348-6352.

9. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med. 2003;138:560-570.

10. Rosai J, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP study group). Am J Surg Pathol. 1996;20:1182-1189.

11. Fletcher CDM, Fletcher JA, Cin PD, et al. Diagnostic gold standard for soft tissue tumors: morphology or molecular genetics? Histopathology. 2001;39:100-103.

12. Ladanyi M. Diagnosis and classification of small round-cell tumors of childhood. Am J Pathol. 1999;155:2181-2182.

13. Rossow KL, Janknecht R. The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res. 2001;61:2690-2695.

14. Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia MA, et al. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene. 2000;19:6015-6022.

15. Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene. 2001;20:5736-5746.

16. Barr FG, Chatten J, D'Cruz CL, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA. 1995;273:553-557.

17. Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000;29:249-258.

18. Adem C, Gisselsson D, Dal Cin P, et al. EVT6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization. Mod Pathol. 2001;14:1246-1251.

19. Hui P, Howe G, Crouch J, et al. Real-time RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohis-tochemistry. Leuk Lymphoma. 2003;44:1385-1394.

20. Athale UH, Shurtleff SA, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmo-plastic small round cell tumor; Am J Pediatr Hematol Oncol. 2001;23: 99-104.

21. Dagher R, Pham RA, Sorbara L, et al. Molecular confirmation of Ewing's sarcoma. Am J Pediatr Hematol Oncol. 2001;23:221-224.

22. Guillou L, Coindre J, Gallaghr G, et al. Detection of the synovial sarcoma translocation t(X;18)(SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists: a molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol. 2001;32:105-112.

23. Sorensen PH, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6:146-151.

24. Giulietti A, Overbergh L, Valckx D, et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods. 2001;25:386-401.

25. Cummings TJ, Brown NM, Stenzel TT. TaqMan junction probes and the reverse transcriptase polymerase chain reaction: detection of alveolar rhabdomyosarcoma, synovial sarcoma, and desmoplastic small round cell tumor. Ann Clin Lab Sci. 2002;32:219-224.

26. Hill DA, Riedley SE, Patel AR, Shurtleff SA, et al. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1

and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital. Pediatr Dev Pathol. 2003;6:24-34.

27. Peter M, Gilbert E, Delattre O. A multiplex real-time PCR assay for the detection of gene fusions observed in solid tumors. Lab Invest. 2001;81:905-912.

28. Hoestein I, Menard A, Bui BN, et al. Molecular detection of the synovial sarcoma translocation t(X;18) by real-time polymerase chain reaction in paraffin-embedded material. Diagn Mol Pathol. 2002;11:16-21.

29. Kumar S, Perlman E, Pack S, et al. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family. Hum Pathol. 1999;30:1356-1360.

30. Parham DM, Shapiro DN, Downing JR, et al. Solid alveolar rhabdomyosarcomas with the t(2;13). Report of two cases with diagnostic implications. Am J Surg Pathol. 1994;18:474-478.

31. Knight JC, Renwick PJ,Cin PD, et al. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24-27.

32. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140:1-12.

33. Kawai A,Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338:153-160.

34. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62: 135-140.

35. Anderson J, Gordon T, McManus A, et al. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer. 2001;85:831-835.

36. Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2002;20:2672-2679.

37. Fidelia-Lambert MN, Zhuang Z, Tsokos M. Sensitive detection of rare Ewing's sarcoma cells in peripheral blood by reverse transcrip-tase polymerase chain reaction. Hum Pathol. 1999;30:78-80.

38. Sumerauer D. Vicha A, Kucerova H, et al. Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR. Folia Biol. 2001;47:206-210.

39. Schleiermacher G, Delattre O. Detection of micrometastases and circulating tumor cells using molecular biology techniques in solid tumors. Bull Cancer. 2001;88:561-570.

40. Worley BS,Van den Broekes LT, Goletz TJ, et al. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res. 2001;61:6868-6875.

41. Van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours. A phase I study. Lancet. 2001;358:1421-1423.

42. Sjoblom T, Shimizu A, O'Brien KP, et al. Growth inhibition of dermatofibrosarcoma protuberant tumors by the platelet-derived growth factor antagonist STI571 though induction of apoptosis. Cancer Res. 2001;61:5778-5783.

43. Simeoni F, Morris MC, Heitz F, et al. Into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 2003;31:2717-2724.

44. Tanaka K, Iwakuma T, Harimaya K, et al. EWS-FLI-1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest. 1997;99:239-247.

45. Uchida A, Seto M, Hashimoto N, et al. Molecular diagnosis and gene therapy in musculoskeletal tumors. J Orthop Sci. 2000;5:418-423.

Chapter 27

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment